CSIMarket Company Name, Ticker, Suppliers, else..
 
Pure Bioscience Inc   (PURE)
 
Price: $0.0551 $-0.01 -21.286%
Day's High: $0.06989999860525131 Week Perf: -31.12 %
Day's Low: $ 0.06 30 Day Perf: -21.29 %
Volume (M): 6,302 52 Wk High: $ 0.11
Volume (M$): $ 0 52 Wk Avg: $0.07
Open: $0.07 52 Wk Low: $0.04



 Market Capitalization (Millions $) 6
 Shares Outstanding (Millions) 111
 Employees 12
 Revenues (TTM) (Millions $) 2
 Net Income (TTM) (Millions $) -2
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Pure Bioscience Inc is a publicly traded company that develops and commercializes unique antimicrobial products for various applications, including food safety, healthcare, and water quality. Their patented technology, called Silver Dihydrogen Citrate (SDC), is a non-toxic and eco-friendly disinfectant that effectively eliminates bacteria, viruses, and fungi. The company's products are used in a wide range of industries to prevent the spread of infectious diseases and promote healthier environments. Pure Bioscience Inc is committed to advancing the science of disinfection and providing sustainable solutions to improve public health.


   Company Address: 771 Jamacha Rd. El Cajon 92019 CA
   Company Phone Number: 596-8600   Stock Exchange / Ticker: PURE


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Business Update

Innovating Clean Pure Biosciences Solution to Dairy and Beverage Industry Challenges

Published Tue, Jun 3 2025 7:54 AM UTC

CSIMarket.com : Overview In recent times, the dairy and beverage industries have faced significant challenges surrounding equipment maintenance and sanitation. As production demands escalate, effective cleaning solutions become paramount. Addressing this pressing need, Pure Bioscience, Inc. based in El Cajon, California, recently unveiled an innovative application method ...
Business Update

PURE Bioscience Expands Market Reach with Strategic Distribution Agreements

Published Wed, Jan 22 2025 8:37 AM UTC

In a decisive move to bolster its market presence and expand its distribution channel, PURE Bioscience, Inc. (OTCQB: PURE), a pioneer in non-toxic antimicrobial solutions, has announced three significant distribution agreements with renowned companies: Hydrite Chemical Company, AFCO (a Zep Company), and Quip Laboratories, Inc. Key Facts: 1. Nature of Agreements : - PUR...
Business Update

Pure Partnerships PURE Biosciences Strategic Alliances to Uphold Antimicrobial Solutions,

Published Tue, Jan 21 2025 9:01 PM UTC

Expanding Horizons: PURE Bioscience Strengthens Market Presence Through Key Distribution Agreements In a strategic move to enhance its foothold within the antimicrobial solutions market, PURE Bioscience, a renowned innovator in developing non-toxic antimicrobial products, has announced a series of pivotal distribution agreements. These partnerships aim to leverage the Silv...
Business Update

A New Era of Hygiene PURE Bioscience Partners with AFCO, a Zep Company

Published Wed, Nov 20 2024 4:47 PM UTC

In a ground-breaking development poised to redefine the landscape of sanitation solutions, PURE Bioscience, Inc. (OTCQB: PURE) has announced a strategic multi-year distribution agreement with AFCO, a Zep Company, renowned for its leadership in the provision of cleaning and sanitation solutions across various industries. This partnership underscores a significant advancement...
Business Update

A Silver Infection Fighter PURE Biosciences Strategic Partnership with Quip Laboratories

Published Sat, Nov 2 2024 3:15 AM UTC

In the evolving world of antimicrobial solutions, PURE Bioscience stands at the forefront with its innovative, non-toxic silver dihydrogen citrate (SDC) technology. Known for its potential to revolutionize sanitation across various sectors, SDC products are gaining attention for their unparalleled effectiveness and safety profile. PURE Bioscience has recently solidified its ...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 2.52
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.27
Working Capital Ratio 0.42
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.02 $
Revenues (TTM) 0.02 $
Cash Flow (TTM) 0 $
Cash 0.01 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 201,833
Net Income per Employee (TTM) -183,750
Receivable Turnover Ratio (TTM) 7.14
Inventory Turnover Ratio (TTM) 4.67
Asset Turnover Ratio (TTM) 2.11

Profitability Ratios Current
Gross Margin (MRQ) 53.16 %
Operating Margin (MRQ) -102.37 %
Net Margin (MRQ) -123.32 %
Net Cash Flow Margin (MRQ) 155.14 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Pure Bioscience Inc's Segments
PURE Hard Surface    18.18 % of total Revenue
SILVERION    81.82 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.